Table 2.
Characteristics of patients and their HCC lesions | BMI |
P-value | |
---|---|---|---|
<30 | ≥30 | ||
Number | 41 (35) | 75 (65) | NA |
Mean BMI | 26±2.5 | 33±2.9 | NA |
Mean age | 57±9 | 59±7 | 0.152 |
Male | 33 (81) | 60 (80) | 0.950 |
HCC first diagnosed by | |||
US | 24 (59) | 14 (19) | <0.001 |
CT | 15 (37) | 50 (67) | |
MRI | 1 (2) | 2 (3) | |
Pathology | 1 (2) | 9 (12) | |
Number of HCC lesions at diagnosis* | 1 (1–2) | 1 (1–2) | 0.734 |
Size of largest HCC lesion at diagnosis* (cm) | 2.2 (1.8–4) | 2 (1.8–3) | 0.373 |
Number of HCC lesions in the explant† | 2 (1–3) | 1 (1–3) | 0.545 |
Sensitivity of US (CI) (%) | 77 (62–93) | 21 (11–30) | <0.001 |
Values are presented as mean±standard deviation, number (%), or median(interquartile range) unless otherwise indicated.
HCC, hepatocellular carcinoma; BMI, body mass index; NA, not applicable; US, ultrasound; CT, computed tomography; MRI, magnetic resonance imaging.
As reported at diagnosis with US, CT, MRI or pathological exam of explant.
As reported on pathological exam of the explant.